Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.40
Delayed Data
As of 2:42pm ET
 0.00 / 0.00%
Today’s Change
1.93
Today|||52-Week Range
4.70
-24.36%
Year-to-Date
Institutional investors purchased a net $782.00 shares of XTLB during the quarter ended September 2017. This may signal that the smart money is gaining interest in this company as the 1.12% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders0.66%
Other institutional0.46%
Individual stakeholders--

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

9/30/2017G1 EXECUTION SERVICES LLC  Bought 11.6 Thousand shares of X T L Biopharmaceuticals ...
9/30/2017MORGAN STANLEY & CO. LLC  Bought 2.5 Thousand shares of X T L Biopharmaceuticals ...
9/30/2017UBS SECURITIES LLC  Sold 13.3 Thousand shares of X T L Biopharmaceuticals ...

Top 10 Owners of X T L Biopharmaceuticals Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Invesco Asset Management Ltd.0.51%25,96158,67200.00%
G1 Execution Services LLC0.23%11,55126,105+11,551--
Morgan Stanley & Co. LLC0.18%9,16020,702+2,500+37.54%
IBI Mutual Funds Management (1978...0.16%8,06018,21600.00%
UBS Securities LLC0.06%3,0406,870-13,269-81.36%

Top 10 Mutual Funds Holding X T L Biopharmaceuticals Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Perpetual Income & Growth Investm...0.38%19,60244,301+108+0.55%
I.B.I. Foreign Equity Liable0.16%8,06018,21600.00%
Keystone Investment Trust Plc0.10%5,16811,680+5,168--
Invesco Perpetual UK 2 Invt. Seri...0.02%1,1912,69200.00%